Mizuho lowered the firm’s price target on Universal Health to $140 from $144 and keeps a Buy rating on the shares. The analyst reduced 2023 estimates to reflect increased interest expense assumptions, driven by the company’s variable rate debt exposure and the increasing interest rate environment.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on UHS:
- Universal Health price target raised to $130 from $114 at RBC Capital
- Universal Health price target lowered to $140 from $155 at Stephens
- Universal Health downgraded to Peer Perform at Wolfe after FY23 guidance
- Universal Health downgraded to Peer Perform from Outperform at Wolfe Research
- Universal Health falls -10.5%